158 related articles for article (PubMed ID: 31520497)
1. Comparing the effectiveness and adverse effects of pilocarpine and cevimeline in patients with hyposalivation.
Farag AM; Holliday C; Cimmino J; Roomian T; Papas A
Oral Dis; 2019 Nov; 25(8):1937-1944. PubMed ID: 31520497
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome.
Noaiseh G; Baker JF; Vivino FB
Clin Exp Rheumatol; 2014; 32(4):575-7. PubMed ID: 25065774
[TBL] [Abstract][Full Text] [Related]
3. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
von Bültzingslöwen I; Sollecito TP; Fox PC; Daniels T; Jonsson R; Lockhart PB; Wray D; Brennan MT; Carrozzo M; Gandera B; Fujibayashi T; Navazesh M; Rhodus NL; Schiødt M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S57.e1-15. PubMed ID: 17379156
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the use of sialogogues in the clinical management of patients with xerostomia.
Chainani-Wu N; Gorsky M; Mayer P; Bostrom A; Epstein JB; Silverman S
Spec Care Dentist; 2006; 26(4):164-70. PubMed ID: 16927740
[TBL] [Abstract][Full Text] [Related]
5. Salivary hypofunction: An update on therapeutic strategies.
Salum FG; Medella-Junior FAC; Figueiredo MAZ; Cherubini K
Gerodontology; 2018 Dec; 35(4):305-316. PubMed ID: 29956369
[TBL] [Abstract][Full Text] [Related]
6. Cevimeline (Evoxac) for dry mouth.
Med Lett Drugs Ther; 2000 Aug; 42(1084):70. PubMed ID: 10932302
[No Abstract] [Full Text] [Related]
7. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
[TBL] [Abstract][Full Text] [Related]
9. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
[TBL] [Abstract][Full Text] [Related]
11. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
Fife RS; Chase WF; Dore RK; Wiesenhutter CW; Lockhart PB; Tindall E; Suen JY
Arch Intern Med; 2002 Jun; 162(11):1293-300. PubMed ID: 12038948
[TBL] [Abstract][Full Text] [Related]
12. A new medication for treatment of dry mouth in Sjögren's syndrome.
al-Hashimi I; Taylor SE
Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of pilocarpine and cevimeline on salivary flow.
Braga MA; Tarzia O; Bergamaschi CC; Santos FA; Andrade ED; Groppo FC
Int J Dent Hyg; 2009 May; 7(2):126-30. PubMed ID: 19416095
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy.
Gorsky M; Epstein JB; Parry J; Epstein MS; Le ND; Silverman S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):190-5. PubMed ID: 14970777
[TBL] [Abstract][Full Text] [Related]
16. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.
Frydrych AM; Davies GR; Slack-Smith LM; Heywood J
Aust Dent J; 2002 Sep; 47(3):249-53. PubMed ID: 12405466
[TBL] [Abstract][Full Text] [Related]
17. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
Fox RI; Konttinen Y; Fisher A
Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
[TBL] [Abstract][Full Text] [Related]
18. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
[TBL] [Abstract][Full Text] [Related]
19. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F
Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]